PanCAN Chief Scientific and Medical Officer Anna Berkenblit discusses how PanCAN supports all patients diagnosed with ...
Jason S. Starr, DO, assistant professor of medicine and a hematologist/oncologist in the Department of Internal Medicine at ...
Regarding efficacy, the phase 1 trial showed impressive objective response rates (ORR), approaching 70%. Typical PRRT alone ...
Acclaimed Indian actor Irrfan Khan passed away at 53 after a battle with a rare neuroendocrine tumor (NET). Diagnosed in 2018 ...
Researchers at Moffitt Cancer Center have developed a novel biomaterial-based system that induces the formation of tertiary ...